Oppenheimer Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-40,434
| Closed | -$3.38M | – | 1208 |
|
|
2024
Q4 | $3.38M | Buy |
40,434
+1,584
| +4% | +$132K | 0.04% | 413 |
|
|
2024
Q3 | $2.84M | Buy |
38,850
+3,358
| +9% | +$246K | 0.03% | 452 |
|
|
2024
Q2 | $2.43M | Buy |
35,492
+6,382
| +22% | +$437K | 0.03% | 474 |
|
|
2024
Q1 | $2.01M | Sell |
29,110
-5,688
| -16% | -$394K | 0.03% | 481 |
|
|
2023
Q4 | $2.49M | Buy |
34,798
+374
| +1% | +$26.8K | 0.03% | 451 |
|
|
2023
Q3 | $1.79M | Buy |
34,424
+2,969
| +9% | +$155K | 0.03% | 526 |
|
|
2023
Q2 | $1.99M | Sell |
31,455
-1,998
| -6% | -$127K | 0.03% | 510 |
|
|
2023
Q1 | $1.81M | Buy |
33,453
+4,160
| +14% | +$225K | 0.03% | 524 |
|
|
2022
Q4 | $1.55M | Sell |
29,293
-1,173
| -4% | -$62.1K | 0.03% | 549 |
|
|
2022
Q3 | $1.42M | Buy |
30,466
+11,877
| +64% | +$553K | 0.03% | 553 |
|
|
2022
Q2 | $1.06M | Sell |
18,589
-5,180
| -22% | -$296K | 0.02% | 657 |
|
|
2022
Q1 | $1.46M | Buy |
23,769
+5,088
| +27% | +$311K | 0.02% | 636 |
|
|
2021
Q4 | $978K | Buy |
18,681
+2,651
| +17% | +$139K | 0.01% | 785 |
|
|
2021
Q3 | $598K | Buy |
+16,030
| New | +$598K | 0.01% | 891 |
|